Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE study experience

This publication has 25 references indexed in Scilit:

• Trends and determinants of calcium antagonist usage after acute myocardial infarction (the GISSI experience)
  The American Journal of Cardiology, 1996
• Calcium antagonists and mortality in patients with coronary artery disease: A Cohort study of 11,575 patients
  Journal of the American College of Cardiology, 1996
• A delayed answer to the calcium blocker question
  Journal of the American College of Cardiology, 1996
• Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group.
  Heart, 1995
• Rationale, design and baseline characteristics of the survival and ventricular enlargement trial
  The American Journal of Cardiology, 1991
• Update of effects of calcium antagonists in myocardial infarction or angina in light of the second danish verapamil infarction trial (DAVIT-II) and other recent studies
  The American Journal of Cardiology, 1991
• Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)
  The American Journal of Cardiology, 1990
• Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
  New England Journal of Medicine, 1989
• The Effect of Diltiazem on Mortality and Reinfarction after Myocardial Infarction
  New England Journal of Medicine, 1988
• Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial Infarction
  New England Journal of Medicine, 1981